Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

known to reduce the risk of virus mutations during production, resulting in a closer match to circulating strains. The platform also enables shorter production timelines, allowing for rapid vaccine supply during pandemics and other infectious...

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

as cellular energy metabolism, cardiovascular health, inflammation, cognitive function, reproductive health, exercise performance, sleep quality, and agricultural applications. The program introduced emerging areas, including Peripheral Artery...

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

around focus, attention, and daily cognitive wellness with AddiVance, a drug-free, non-stimulant dietary supplement formulated to support focus, attention, mood balance, and everyday cognitive performance. For many parents, focus support is not an...

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

multiple resistance genes and can support same-day reporting depending on laboratory workflow. This can provide timely information to support infection-control responses and complement conventional culture-based workflows. It may also help support...

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

aim to support people in administering insulin more confidently in their daily routine, while building on the trusted performance associated with the CONTOUR® brand.” 1 CONTOUR COMFORT pen needles have been developed to support ease of use in daily...

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

with unmet medical needs in pain/CNS, including Alzheimer’s disease, oncology, rare diseases, and sleep apnea. For more information on Shionogi & Co., Ltd. For more information please visit https://www.shionogi.com/global/en.

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

mCRPC, it is incredibly important to have high-quality tissue- and blood-based companion diagnostics available to best inform personalized treatment plans for each unique patient,” said Todd Druley, M.D., Ph.D., Chief Medical Officer at Foundation...

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

for regulatory creativity grounded in science rather than institutional defensiveness. ALS patients cannot afford performative skepticism from regulators sitting comfortably outside the blast radius of this disease." "I look forward to working with...

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

has been completed. VOWST is not intended for treatment of C. diff infection. Please see the full U.S. Prescribing Information for the complete Indication and Important Safety Information below. This press release contains forward-looking...

Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

has been dosed in an investigator initiated trial (IIT) using ImmuXell’s TCR-T cell therapy manufactured on Ori’s IRO® platform. The IIT is aiming to evaluate ImmuXell’s TCR-T therapy in patients with solid tumors harboring KRAS G12V mutations,...

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

continues to support these efforts through initiatives aimed at strengthening regional innovation and manufacturing platforms, enhancing regulatory systems, and expanding joint procurement mechanisms across the region." Lucía Ayala, President of...

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

study. "The 72- and 124-week open-label extension studies, which over 90% of participants completed, provide further information on lerodalcibep’s longer term robust and sustained reductions in LDL-C and other lipids and lipoproteins, safety and...

Digi-Tech Pharma & AI Conference 2026

technologies and practical solutions. In this 8th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial...

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and...

Hologic to Present New Data Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

only genomic assay shown to predict who is likely to benefit from extended endocrine therapy beyond five years.2,3 More information on these findings will be presented at the 2026 ASCO Annual Meeting on June 1. The data come from a new analysis of...

Aspera Biomedicines launched its second ADAR1p150 crystallization to the ISS aboard SpaceX CRS-34

as part of a NASA InSPA Phase 2 award to further elucidate the mechanism of action of Rebecsinib and to develop an oral formulation for clinical trials in a broad array of advanced malignancies,” said Dr. Catriona Jamieson, Founder and Board Member...

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

Aliya PEF while preserving the biologic mechanism, procedural consistency, and workflow integration that define our platform." About Aliya® PEF Energy Aliya EX delivers high-voltage, short-duration electrical energy locally to induce non-thermal...

Peter Menziuso named EVP and President of BD Interventional

medical affairs. Throughout his career, Menziuso has been recognized for strengthening market leadership, building high‑performing teams and translating strategy into sustained performance through commercial rigor and operational excellence. His...

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

been reported. “These new data add to the growing body of real-world evidence generated in urology practices and help inform how re-induction with ADSTILADRIN is being evaluated outside of the controlled clinical trial setting, particularly in a...

Biohack skin longevity with Futurecode Booster

The concept of biohacking often brings to mind performance tracking and high-tech optimization – but at its core, it's a mindset grounded in understanding how the body functions and supporting it to work more efficiently. From adding collagen to...